What is Wedbush’s Forecast for CGEM FY2029 Earnings?
Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) – Analysts at Wedbush issued their FY2029 EPS estimates for shares of Cullinan Therapeutics in a research report issued to clients and investors on Thursday, February 27th. Wedbush analyst R. Driscoll forecasts that the company will post earnings of ($2.22) per share for the year. The consensus estimate […]
Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) – Analysts at Wedbush issued their FY2029 EPS estimates for shares of Cullinan Therapeutics in a research report issued to clients and investors on Thursday, February 27th. Wedbush analyst R. Driscoll forecasts that the company will post earnings of ($2.22) per share for the year. The consensus estimate […]
